Sharon Bio-Medicine Ltd-$ (Delisted) share news and announcements

BSE: 532908Pharmaceuticals & Biotechnology

Last traded ₹3.30 on 28 Mar 2019

Delisted on 20 Feb 2024.

Sharon Bio-Medicine Ltd-$ share news and announcements

831 announcements, routine notices left out, newest first. Page 2 of 17.

Dec 2022
- 5 Dec · General updates
  Response to your mail dated 17th November 2022 in the matter of Sharon Bio-Medicine Limited (opens in a new tab)
Nov 2022
- 25 Nov · CIRP - Approval of Resolution Plan
  Sub: Update on filing of the plan approval application in the matter of Sharon Bio-Medicine LimitedPursuant to the intimation dated 22nd November 2022, wherein we have informed that the Committee of Creditors(CoC) of Sharon Bio-Medicine Limited has approved the resolution plan with requisite majority as per Section 30(4)of the IBC, 2016. Kindly note that the undersigned has filed the plan approval application under Section 30(6) of theInsolvency and Bankruptcy Code, 2016 with the Hon ble NCLT, Mumbai on 21st November 2022.Kindly take the same on your records (opens in a new tab)
- 25 Nov · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
  Pursuant to the intimation dated 22nd November 2022, wherein we have informed that the Committee of Creditors (CoC) of Sharon Bio-Medicine Limited has approved the resolution plan with .... (opens in a new tab)
- 22 Nov · CIRP - Committee meeting updates
  We hereby inform that the Committee of Creditors (CoC) of Sharon Bio-Medicine Limited has approved the resolution plan with requisite majority as per Section 30(4) of the IBC, 2016. Subsequently, the COC approved resolution plan has been filed with Hon'ble National Company Law Tribunal, Mumbai Bench on 22nd November, 2022 for its approval in accordance with Section 30(6) of the IBC, 2016. (opens in a new tab)
- 22 Nov · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  We hereby inform that the Committee of Creditors (CoC) of Sharon Bio-Medicine Limited .... (opens in a new tab)
- 21 Nov · CIRP - Committee meeting updates
  Update on committee of creditors meeting (opens in a new tab)
- 21 Nov · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  We hereby inform that the Committee of Creditors (CoC) of Sharon Bio-Medicine Limited .... (opens in a new tab)
- 11 Nov · Board meeting
  Un-audited Financial Results for the quarter and half year ended September 30, 2022 (opens in a new tab)
- 11 Nov · Results
  Dear Sir/Madam, Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirement) Regulations, 2015, we enclose herewith the Un-audited Financial Results of the Company .... (opens in a new tab)
- 2 Nov · Board meeting
  Declaration of Un-audited Financial Results for the quarter and half year ended September 30, 2022 (opens in a new tab)
- 2 Nov · Board meeting
  SHARON BIO-MEDICINE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve Dear Sir/Madam, Pursuant .... (opens in a new tab)
Oct 2022
- 28 Oct · General updates
  Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 (opens in a new tab)
- 13 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 7 Oct · CIRP - Committee meeting updates
  Update on committee of creditors meeting (opens in a new tab)
- 7 Oct · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Outcome of the 20th Committee of Creditors ('CoC') Meeting in the matter of Sharon Bio-Medicine Limited (opens in a new tab)
- 3 Oct · Management
  Resignation of Komal Mota as Company Secretary of the company w.e.f. 03-Oct-2022 (opens in a new tab)
- 3 Oct · Management
  Intimation for Resignation of Company Secretary (opens in a new tab)
Sep 2022
- 19 Sep · CIRP - others
  Update on corporate insolvency resolution process (opens in a new tab)
- 19 Sep · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
  Update in the matter of Corporate Insolvency Resolution Process (CIRP) (opens in a new tab)
- 15 Sep · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Outcome of COC (opens in a new tab)
- 15 Sep · CIRP - Committee meeting updates
  Update on committee of creditors meeting (opens in a new tab)
- 8 Sep · CIRP - Committee meeting updates
  Update on committee of creditors meeting (opens in a new tab)
- 8 Sep · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  COC meeting of Sharon Bio- Medicine Limited (opens in a new tab)
- 1 Sep · CIRP - others
  Update on corporate insolvency resolution process (opens in a new tab)
- 1 Sep · Corporate Insolvency Resolution Process (CIRP)-Resolution Plans received by Resolution Professional
  Intimation on receipt of Resolution Plans received in the matter of Sharon bio- Medicine Limited (opens in a new tab)
Aug 2022
Jul 2022
- 25 Jul · CIRP - others
  Update on corporate insolvency resolution process (opens in a new tab)
- 25 Jul · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
  Publication of Final List of Prospective Resolution Applicants eligible for submitting Resolution Plan for Sharon Bio-Medicine Limited (opens in a new tab)
- 19 Jul · General updates
  Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 (opens in a new tab)
- 14 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 7 Jul · CIRP - Committee meeting updates
  Update on committee of creditors meeting (opens in a new tab)
- 7 Jul · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Outcome of the 13th Committee of Creditors ('CoC') Meeting in the matter of Sharon Bio-Medicine Limited. (opens in a new tab)
Jun 2022
- 21 Jun · CIRP - Committee meeting updates
  Update on committee of creditors meeting (opens in a new tab)
- 21 Jun · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Outcome of Committee of Creditors ('CoC') Meeting in the matter of Sharon Bio-Medicine Limited (opens in a new tab)
- 21 Jun · CIRP - Committee meeting updates
  Update on committee of creditors meeting (opens in a new tab)
- 21 Jun · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
  Outcome of the 11th Committee of Creditors ('CoC') Meeting & Intimation of publication of FORM -G: Invitation for Expression of Interest in the matter of Sharon Bio- Medicine Limited) (opens in a new tab)
- 9 Jun · CIRP - Commencement
  Commencement of corporate insolvency resolution process (opens in a new tab)
- 9 Jun · Management
  Intimation of re-initiation of Corporate Insolvency Resolution Process (CIRP) and appointment of Interim Resolution Professional (IRP) (opens in a new tab)
- 6 Jun · Communication to shareholders as per Reg 30
  Communication to shareholders as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (opens in a new tab)
- 6 Jun · NCLT Order Copy Dated 3Rd June, 2022
  Copy of order passed by NCLT, Mumbai on 3rd June, 2022. Kindly take the same on your records. (opens in a new tab)
May 2022
- 18 May · Management
  Dear Sir/Madam, The Audited Financial Results for the quarter and year ended March 31, 2022 were published by the Company on May 17, 2022. However, there was a typo error in .... (opens in a new tab)
- 18 May · General updates
  Revised Auditor's Report for the quarter and year ended March 31, 2022 (opens in a new tab)
- 17 May · Board meeting
  Board Meeting held on 17-May-2022 to consider financial statements for the period ended March 2022 (opens in a new tab)
- 17 May · Board meeting
  Following documents are enclosed: Audited financial results for the quarter .... (opens in a new tab)
- 17 May · Results
  Following documents are enclosed: Audited financial results for the quarter .... (opens in a new tab)
- 17 May · Results
  Financial results for the period ended March 31, 2022. (opens in a new tab)
- 6 May · Board meeting
  Declaration of Financial Results for the quarter and year ended March 31, 2022 (opens in a new tab)